Emerging Company Profile
IgGenix: antibody engineering for food allergies
IgGenix is blocking the inflammatory response in food allergies with redesigned antibodies
IgGenix is designing a new type of food allergy therapy by reprogramming how allergenic antibodies interact with the immune system.
IgGenix is pairing single-cell sequencing with antibody engineering to create a new class of food allergy therapies that selectively suppresses allergen-triggered immunity while sidestepping the risky steps